[LXRX] YoY Quarter Result on 30-Sep-2016 [#Q3]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
07-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- 5.50%
YoY- -2.08%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Revenue 294,448 6,856 26,942 27,717 566 419 238 227.46%
PBT 220,072 -27,512 -30,722 -36,015 -35,282 -40,498 -31,658 -
Tax -6,014 783 2,034 1,135 1,627 205 503 -
NP 226,086 -27,512 -30,722 -36,015 -35,282 -40,498 -31,658 -
Tax Rate 2.73% - - - - - - -
Total Cost 68,362 34,368 57,664 63,732 35,848 40,917 31,896 13.54%
Ratio Analysis
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
NP Margin 76.78 -401.28 -114.03 -129.94 -6,233.57 -9,665.39 -13,301.68 -
Per Share
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
EPS 2.13 -0.26 -0.29 -0.35 -0.34 -0.55 -0.43 -
EPS Diluted 1.95 -0.26 -0.29 -0.35 -0.34 -0.55 -0.43 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.